| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4145732 | Archives de Pédiatrie | 2015 | 9 Pages |
Abstract
Personalized medicine, or P4 medicine for “Personalized”, “Predictive”, “Preventive” and “Participatory”, is currently booming for cystic fibrosis, with the development of therapies targeting specific CFTR mutations. The various challenges of personalized medicine applied to cystic fibrosis issues are discussed in this paper.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
H. Corvol, J. Taytard, O. Tabary, P. Le Rouzic, L. Guillot, A. Clement,